Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorNanjing First Hospital, Nanjing Medical University
About this trial
This study aimed to compare the clinical and angiographic outcomes of patients with DES-ISR who underwent repeat PCI with intravascular imaging or angiographic guidance.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
The first-time drug-eluting stent in-stent restenosis (DES-ISR) who underwent repeat percutaneous coronary intervention (re-PCI) under angiographic guidance or combined IVUS guidance.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
percutaneous coronary intervention
Procedure/SurgeryPercutaneous Coronary Intervention for ISR
Treatment groups
1,500 Participants
are divided into 2 treatment groupsGroup A: Intravascular imaging -guidance1 intervention
Group B: Angiography-guidance1 intervention
Trial outcomes
Primary outcomes
1
MACE
Major adverse cardiovascular events following PCI
Time frame
3-yearSecondary outcomes
1
Stent expansion
defined as the final minimal luminal area (MLA) within the treatment segment divided by the average reference vessel area
Time frame
Intraprocedural2
MSA
minimal stent area
Time frame
IntraproceduralSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov